Clinical trial

Celecoxib for Treatment of Postoperative Pain After Osteosynthesis of Distal Radius Fracture

Name
Celecoxib in radius fracture
Description
Patients scheduled for elective osteosynthesis of the distal radius will be randomized to receive celecoxib 100 mg orally (PO) at 6 in the morning before surgery and every 12 hours for 2 days thereafter, or a placebo pill in the same regimen. After surgery under general anaesthesia, they will receive paracetamol 1 g intravenously (IV) every 6 hours and if pain intensity is greater than 4 on a numeric rating scale (NRS) of 0-10, piritramid 15 mg intramuscularly (IM) will be administered. Pain intensity, piritramid consumption and side effects of treatment will be recorded in a questionnaire for 2 days.
Trial arms
Trial start
2022-02-10
Estimated PCD
2023-11-30
Trial end
2023-12-31
Status
Completed
Phase
Early phase I
Treatment
Celecoxib 100 mg
Administering Celecoxib 100 mg (Celebrex) regularly every 12 hours for 3 days starting at 6 in the morning on the day of surgery
Arms:
Celecoxib
Other names:
Celebrex 100 mg
Placebo
Administering placebo regularly every 12 hours for 3 days starting at 6 in the morning on the day of surgery
Arms:
Placebo
Other names:
Placebo pill
Size
42
Primary endpoint
Postoperative pain intensity
up to 2 days
Eligibility criteria
Inclusion Criteria: * Patients scheduled for osteosynthesis of distal radius fracture Exclusion Criteria: * Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib * History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. * Patients who have demonstrated allergic-type reactions to sulfonamides. * Inability to understand the questionnaire
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Celecoxib 100 mg orally on the day of surgery at 6 in the morning and will be continued regularly at 6 in the morning and 6 in the afternoon for 3 days.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': 'Placebo pill provided by a hospital pharmacy will be administered orally on the day of surgery at 6 in the morning and will be continued regularly at 6 in the morning and 6 in the afternoon for 3 days.', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 42, 'type': 'ACTUAL'}}
Updated at
2024-02-07

1 organization

1 product

1 drug

2 indications

Organization
Charles University
Product
Celecoxib
Indication
Pain
Indication
Postoperative